SUN PHARMA ADVANCED RESEARCH COMPANY LTD.

NSE : SPARCBSE : 532872ISIN CODE : INE232I01014Industry : Business SupportHouse : Sun Pharma
BSE369.951.15 (+0.31 %)
PREV CLOSE ( ) 368.80
OPEN PRICE ( ) 374.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5355
TODAY'S LOW / HIGH ( )365.05 374.90
52 WK LOW / HIGH ( )173.55 423.6
NSE368.30-3.8 (-1.02 %)
PREV CLOSE( ) 372.10
OPEN PRICE ( ) 370.25
BID PRICE (QTY) 368.30 (34079)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 151452
TODAY'S LOW / HIGH( ) 363.10 374.00
52 WK LOW / HIGH ( )174.7 423.35

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.